Fundamental Analysis of Medirom Healthcare Tech Inc. - Growth / Value Index
MRM - Valuation Highlights
Valuation Analysis
Price to Earning Ratio is 0.094 and EV to EBITDA is 9.48 suggesting company is undervalued.
Tsr Value Index - Poor Score of 25.00
Book value is negative
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 0.102 | 0.194 | 773.35 % | |
| Price to Book | -0.111 | -0.488 | -255.24 % | -0.070 |
| Price to Sales | -0.0082 | 0.0042 | -21.24 % | |
| Enterprise Value to EBITDA Multiple | 9.49 | 4.02 | 184.00 % |
MRM - Profitability Highlights
Profitability Analysis
Earning Yield of 1069.21 %
Net profit has jumped from negative to positive
Company Earning excess return
Piotroski F Score - Stable Value of 5.0
Annual Net Profit in last 3 years is trending up
EBITDA is continuously increasing for last 3 Years
Good Return On Capital Employed of 12.52
Very Low Dividend Yield of 0 %
In the last three years, the company has given poor Net Margin
In the last three years, the company has given poor Returns on Equity
In the last three years, the company has given poor Returns on Assets
EPS decline for last four quarters
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 0 | 0 | 0 % | 0 |
| Return On Asset | 3.35 | 2.21 | 112.82 % | 0 |
| Net Profit Margin | -8.08 | 2.14 | 111.70 % | 0 |
| Operating Profit Margin | -6.75 | 2.51 | 128.89 % | 0 |
| EBITDA Margin | -5.77 | 5.16 | 201.03 % | 0 |
Highlights
| Market Cap | 28962.99 K |
| Enterprise Value | 1442.21 M |
| Price/Book TTM | -0.111 |
| Outstanding Share | 4882.50 K |
| Float/ Outstanding Share | 61.39% |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | |
| Peter Lynch Ratio | 0 |
| Piotroski F Score | 5.00 |
| Altman Z Score | 0.391 |
| Sloan Ratio | 0.124 |
| Peter Lynch Fair Value | 1453.44 |
MRM - Growth Highlights
Growth Analysis
Annual sales of the company is increased for three years in a row
Quarterly sales in last 5 years is trending up
Steady increase in Total Assets for last 3 Years
Tsr Growth Index - Poor Score of 21.38
Operating Cash Flow decreasing for last 3 year
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | -2632.27 M | 28.54 % | % |
| Gross Profit | -4745.63 M | 34.41 % | % |
| EBITDA | 151925 K | 229.86 % | % |
| Net Profit | 212818 K | 115.04 % | % |
| EPS | 58.14 | 114.85 % | NA |
MRM - Stability Highlights
Stability Analysis
Debt to equity ratio has decreased and is lowest in last three years
Altman Z Score of 0.391 suggest high risk
Company is unable to generate enough free cash to support the business.
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | -34.00 | -325.65 % | -4.69 |
| Cash Ratio | 0.174 | 39.66 % | |
| Quick Ratio | 0.618 | 44.76 % | 0.419 |
| Shareholders Equity | -0.880 | 75.70 % | |
| Debt to EBITDA | 5.63 | 193.41 % |
Historical Valuation Ratios of Medirom Healthcare Tech Inc.
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Medirom Healthcare Tech Inc.
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Medirom Healthcare Tech Inc.
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Medirom Healthcare Tech Inc.
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)